| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31f82ee7f02c84fc229937f6286d6c76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a9853ad95797cbc7edefa58a5eef357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb5c2fdb36fc693d49c16adacfadda97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c15c9ec7cde08c75ce9bfd98ae33e792
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02baa804e1b783b14ec472d82836ad5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-221 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate |
2014-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36bb5502dfda8a62d82825366afe7d43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b57cf79e485fc64ee0a3e4242f4de5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_750c6cfc4948083b80fad62e2eed096e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e7997787203d12c7a16675706f11d0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f78205d3de561b66fe9e16307296830 |
| publicationDate |
2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014329872-A1 |
| titleOfInvention |
Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy |
| abstract |
The invention relates to methods and pharmaceutical compositions for treating hypertension and/or preventing or treating heart failure in a mammal receiving anti-coagulant therapy using compound(s) which are therapeutically effective but do not impact the pharmacokinetic or the pharmacodynamic effect(s) of the anti-coagulant, such as warfarin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016049663-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10508087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3443960-A1 |
| priorityDate |
2010-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |